Hgk Asset Management Inc Meridian Bioscience Inc Transaction History

Hgk Asset Management Inc

  • $533 Million
  • Q4 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 29, 2022
SELL
$23.75 - $31.69 $445,597 - $594,567
-18,762 Closed
0 $0
Q1 2022

May 04, 2022
SELL
$19.97 - $26.94 $365,371 - $492,894
-18,296 Reduced 49.37%
18,762 $487,000
Q4 2021

Feb 01, 2022
BUY
$17.46 - $21.61 $156,546 - $193,755
8,966 Added 31.92%
37,058 $756,000
Q3 2021

Oct 28, 2021
BUY
$17.35 - $22.5 $487,396 - $632,070
28,092 New
28,092 $540,000

Others Institutions Holding VIVO

# of Institutions
10
Shares Held
113K
Call Options Held
0
Put Options Held
0
View Full List

About MERIDIAN BIOSCIENCE INC

VIVO Quotes by TradingView
  • Ticker VIVO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 43,748,000
  • Description
  • Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...
More about VIVO
Track This Portfolio

Track Hgk Asset Management Inc Portfolio

Follow Hgk Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hgk Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Hgk Asset Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email